BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression Profiles of Breast Tumors from Singapore and Europe

Dataset: Expression Profiles of Breast Tumors from Singapore and Europe

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that...

Registered by ArrayExpress Uploader
View Dataset

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes, we recently compiled a meta-analytical database of over 2,000 human breast tumor expression profiles variously annotated for clinical and pathological variables and derived from various institutions worldwide. This database was utilized for the breast tumor study cited below: Nagalla, et. al., Genome Biology, 2013. While the majority of the tumor expression profiles included in this database derived from publicly accessible microarray repositories, a number of the samples had not been previously published. Here, we describe the origin of these samples and provide their associated clinical and pathological annotations with the hope that other investigators will be able to utilize these data in their own research. Breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore) were profiled on the Affymetrix U133A platform. The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Species:
human

Samples:
139

Source:
E-GEOD-45255

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample LN STATUS CHARACTERISTICS DMFS TIME HISTOLOGICAL GRADE SIZE MM TREATMENT TYPE DFS TIME DSS TIME DMFS EVENT DEFINED AS DISTANT METASTASIS OR DEATH FROM BREAST CANCER PGR STATUS HISTOLOGY HER2 STATUS DSS EVENT DEFINED AS DEATH FROM BREAST CANCER ER STATUS YES DFS EVENT DEFINED AS ANY TYPE OF RECURRENCE OR DEATH FROM BREAST CANCER PATIENT AGE
GSM1100175 LN- endocrine? (0=no, 1=yes): 0 9.419 G1 21 none 9.42 NA not specified NA NA NA NA ER+ not specified not specified 43
GSM1100174 LN- endocrine? (0=no, 1=yes): 0 10.614 G2 23 none 10.61 NA not specified NA NA NA NA ER- not specified 1 37
GSM1100173 LN- endocrine? (0=no, 1=yes): 0 7.151 NA 10 none 7.15 NA 1 NA NA NA NA ER- not specified 1 67
GSM1100172 LN- endocrine? (0=no, 1=yes): 0 1.66 G3 29 CMFx6 NA 1.66027397260274 not specified PgR- NA He- not specified ER- 1 NA 50
GSM110017 LN- endocrine? (0=no, 1=yes): 1 4.51 G2 20 tamoxifen NA 4.50958904109589 not specified PgR- NA He- not specified ER+ 1 NA 72
GSM1100170 LN- endocrine? (0=no, 1=yes): 1 3.93 G1 30 tamoxifen NA 3.92602739726027 not specified PgR+ NA He+ not specified ER+ 1 NA 56
GSM1100169 LN- endocrine? (0=no, 1=yes): 1 4.96 G3 27 CMFx6; Tamoxifen NA 4.95890410958904 not specified PgR- NA He- not specified ER- 1 NA 46
GSM1100168 LN- endocrine? (0=no, 1=yes): 1 4.56 G2 30 tamoxifen NA 4.56164383561644 not specified PgR+ NA He+ not specified ER+ 1 NA 45
GSM1100167 LN- endocrine? (0=no, 1=yes): 0 5.01 G3 60 CMFx6 NA 5.00821917808219 not specified PgR- NA He+ not specified ER- 1 NA 48
GSM1100166 LN- endocrine? (0=no, 1=yes): 0 4.64 G2 20 CMFx6 NA 4.64383561643836 not specified PgR+ NA He- not specified ER+ 1 NA 45
GSM1100165 LN- endocrine? (0=no, 1=yes): 1 5.13 G2 20 tamoxifen NA 5.13424657534247 not specified PgR- NA He- not specified ER+ 1 NA 70
GSM1100164 LN- endocrine? (0=no, 1=yes): 0 6.26 G3 45 ACx4 NA 6.25753424657534 not specified PgR- NA NA not specified ER- 1 NA 59
GSM1100163 LN- endocrine? (0=no, 1=yes): 1 5.57 G3 14 CMFx6; Arimidex/Tamoxifen NA 5.56712328767123 not specified PgR- NA He- not specified ER- 1 NA 61
GSM1100162 LN- endocrine? (0=no, 1=yes): 1 5.11 G3 20 ACx4; Arimidex/Tamoxifen NA 5.10958904109589 not specified PgR+ NA He- not specified ER+ 1 NA 60
GSM110016 LN- endocrine? (0=no, 1=yes): 1 5.52 G3 19 tamoxifen NA 5.52328767123288 not specified PgR+ NA He- not specified ER+ 1 NA 53
GSM1100160 LN- endocrine? (0=no, 1=yes): 0 6.69 G2 14 CMFx6 NA 6.69315068493151 not specified PgR+ NA He- not specified ER+ 1 NA 42
GSM1100159 LN- endocrine? (0=no, 1=yes): NA 6.19 NA 38 NA NA 6.18630136986301 not specified PgR- NA He- not specified ER- NA NA 73
GSM1100158 LN- endocrine? (0=no, 1=yes): 1 2.57 G3 32 CMFx6; Tamoxifen NA 2.57260273972603 not specified NA NA NA not specified NA 1 NA 46
GSM1100157 LN- endocrine? (0=no, 1=yes): 1 3.12 G1 20 tamoxifen NA 3.11506849315069 not specified PgR- NA He+ not specified ER+ 1 NA 57
GSM1100156 LN- endocrine? (0=no, 1=yes): 1 5.94 G1 27 tamoxifen NA 5.93698630136986 not specified PgR+ NA He- not specified ER+ 1 NA 66
GSM1100155 LN- endocrine? (0=no, 1=yes): 1 6.13 G3 27 tamoxifen NA 6.12876712328767 not specified PgR+ NA He+ not specified ER+ 1 NA 62
GSM1100154 LN- endocrine? (0=no, 1=yes): 1 6.61 G3 40 ACx6; Tamoxifen NA 6.61369863013699 not specified PgR- NA He- not specified ER- 1 NA 67
GSM1100153 LN- endocrine? (0=no, 1=yes): 1 6.65 G2 35 tamoxifen NA 6.65205479452055 not specified PgR- NA He+ not specified ER+ 1 NA 70
GSM1100152 LN- endocrine? (0=no, 1=yes): 1 6.18 G2 15 tamoxifen NA 6.17534246575342 not specified PgR+ NA He+ not specified ER+ 1 NA 77
GSM110015 LN- endocrine? (0=no, 1=yes): 1 6.02 G2 20 ACx4; Tamoxifen NA 6.01917808219178 not specified PgR- NA He+ not specified ER- 1 NA 52
GSM1100150 LN- endocrine? (0=no, 1=yes): 1 7.57 G2 20 tamoxifen NA 7.57260273972603 not specified PgR- NA He+ not specified ER+ 1 NA 81
GSM1100149 LN- endocrine? (0=no, 1=yes): 1 7.31 G3 18 tamoxifen NA 7.30684931506849 not specified PgR+ NA He- not specified ER+ 1 NA 55
GSM1100148 LN- endocrine? (0=no, 1=yes): 1 7.85 G2 12 Tamoxifen+Zoledronic acid NA 7.85479452054795 not specified NA NA He+ not specified ER+ 1 NA 48
GSM1100147 LN- endocrine? (0=no, 1=yes): 1 7.82 G2 10 tamoxifen NA 7.82191780821918 not specified PgR- NA He- not specified ER- 1 NA 54
GSM1100146 LN- endocrine? (0=no, 1=yes): 1 3.30 G3 37 Arimidex/Tamoxifen NA 5.16438356164384 1 PgR+ NA He+ not specified ER+ 1 NA 72
GSM1100145 LN- endocrine? (0=no, 1=yes): 1 3.65 G3 40 CMFx2; Tamoxifen NA 6.75068493150685 1 PgR+ NA He- not specified ER+ 1 NA 60
GSM1100144 LN- endocrine? (0=no, 1=yes): 0 6.15 G1 55 ACx4 NA 8.02191780821918 1 PgR- NA He- not specified ER+ 1 NA 54
GSM1100143 LN- endocrine? (0=no, 1=yes): 1 2.42 G2 13 Tamoxifen+Zoledronic acid NA 7.07945205479452 1 PgR- NA He- not specified ER- 1 NA 36
GSM1100142 LN- endocrine? (0=no, 1=yes): 1 2.18 G1 10 Tamoxifen+Zoledronic acid NA 2.18904109589041 not specified PgR- NA He- not specified ER+ 1 NA 46
GSM110014 LN- endocrine? (0=no, 1=yes): 1 0.76 G3 35 tamoxifen NA 0.991780821917808 1 PgR+ NA He+ 1 ER+ 1 NA 70
GSM1100140 LN- endocrine? (0=no, 1=yes): 0 3.80 G3 34 ACx3/CMFx1 NA 4.62191780821918 1 PgR- NA He- 1 ER- 1 NA 73
GSM1100139 LN- endocrine? (0=no, 1=yes): 1 2.21 G3 46 tamoxifen NA 4.92876712328767 1 PgR+ NA He- 1 ER+ 1 NA 63
GSM1100138 LN- endocrine? (0=no, 1=yes): 1 1.35 G3 32 ECx4; Tamoxifen NA 2.75342465753425 1 PgR- NA He- 1 ER+ 1 NA 38
GSM1100137 LN- endocrine? (0=no, 1=yes): 1 0.25 NA 85 tamoxifen NA 5.03561643835616 1 PgR+ NA He+ 1 ER+ 1 NA 57
GSM1100136 LN- endocrine? (0=no, 1=yes): 1 4.51 G3 17 tamoxifen NA 6.17260273972603 1 PgR+ NA He- 1 ER+ 1 NA 68
GSM1100135 LN- endocrine? (0=no, 1=yes): 1 4.18 G3 21 tamoxifen NA 4.19452054794521 1 PgR- NA He- 1 ER- 1 NA 66
GSM1100134 LN- endocrine? (0=no, 1=yes): 1 0.65 G3 25 tamoxifen NA 3.07945205479452 1 PgR- NA He+ 1 ER- 1 NA 59
GSM1100133 LN- endocrine? (0=no, 1=yes): 1 1.39 G3 28 CMFx6; Tamoxifen NA 2.12602739726027 1 PgR+ NA He+ 1 ER+ 1 NA 47
GSM1100132 LN- endocrine? (0=no, 1=yes): 1 3.05 G2 30 tamoxifen NA 3.44931506849315 1 NA NA He+ 1 ER+ 1 NA 63
GSM110013 LN+ endocrine? (0=no, 1=yes): 1 4.33 G3 35 Tam+CMFx6 cycles 4.33 4.33 not specified PgR+ invasive ductal carcinoma NA not specified ER+ 1 not specified 53
GSM1100130 LN+ endocrine? (0=no, 1=yes): NA 4.83 G1 60 NA 4.83 4.83 not specified PgR+ invasive ductal carcinoma He- not specified ER+ NA not specified 59
GSM1100129 LN- endocrine? (0=no, 1=yes): 1 4.38 G3 20 tamoxifen 4.38 4.38 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 62
GSM1100128 LN+ endocrine? (0=no, 1=yes): 1 2.67 G1 24 Tam+ACx4 cycles 2.67 2.67 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 43
GSM1100127 LN- endocrine? (0=no, 1=yes): 0 4.67 G1 25 none 4.67 4.67 not specified NA invasive ductal carcinoma and papillary carcinoma NA not specified NA not specified not specified 55
GSM1100126 LN- endocrine? (0=no, 1=yes): 1 0.83 G3 28 tamoxifen 0.83 0.83 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 84
GSM1100125 LN+ endocrine? (0=no, 1=yes): 1 2.00 G3 40 Tam+AC 2.00 2.00 1 PgR+ invasive ductal carcinoma He+ not specified ER+ 1 1 38
GSM1100124 LN+ endocrine? (0=no, 1=yes): 1 4.92 G3 25 tamoxifen 4.92 4.92 not specified PgR- invasive ductal carcinoma He+ not specified ER+ 1 not specified 67
GSM1100123 LN- endocrine? (0=no, 1=yes): 1 5.17 G1 20 tamoxifen 5.17 5.17 not specified PgR+ invasive lobular carcinoma He- not specified ER+ 1 not specified 52
GSM1100122 LN+ endocrine? (0=no, 1=yes): 1 3.83 G3 16 Tam+ACx4 cycles 3.83 5.75 1 PgR+ invasive ductal carcinoma He+ not specified ER- 1 1 50
GSM110012 LN- endocrine? (0=no, 1=yes): 1 5.21 G3 50 tamoxifen 5.21 5.21 not specified PgR+ medullary carcinoma He+ not specified ER+ 1 not specified 64
GSM1100120 LN+ endocrine? (0=no, 1=yes): 0 4.54 G3 30 CAF 4.54 4.54 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 47
GSM1100119 LN- endocrine? (0=no, 1=yes): 1 5.58 G3 38 Tam+ACx4 cycles 5.58 5.58 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 38
GSM1100118 LN+ endocrine? (0=no, 1=yes): 1 5.92 G3 51 Tam+ACx4 cycles 5.92 5.92 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 58
GSM1100117 LN- endocrine? (0=no, 1=yes): 0 5.88 G3 21 ACx4 cycles 5.88 5.88 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 not specified 47
GSM1100116 LN- endocrine? (0=no, 1=yes): 1 5.79 G3 18 Tam+CMFx6 cycles 5.79 5.79 not specified PgR- invasive ductal carcinoma He- not specified ER+ 1 not specified 51
GSM1100115 LN- endocrine? (0=no, 1=yes): 0 5.83 G3 35 ACx4 cycles 5.83 5.83 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 not specified 48
GSM1100114 LN- endocrine? (0=no, 1=yes): 0 5.83 G3 25 ACx4 cycles 5.83 5.83 not specified PgR- invasive ductal carcinoma He- not specified ER- 1 not specified 46
GSM1100113 LN- endocrine? (0=no, 1=yes): 0 1.33 G3 27 ACx4 cycles 1.92 5.58 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 1 51
GSM1100112 LN- endocrine? (0=no, 1=yes): 1 6.17 G3 25 Tam+CMFx6 cycles 6.17 6.17 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 36
GSM1100 LN+ endocrine? (0=no, 1=yes): 0 5.83 G3 15 CAFx6 cycles 5.83 5.83 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 not specified 61
GSM1100110 LN- endocrine? (0=no, 1=yes): 0 5.71 G3 32 ACx4 cycles 5.71 5.71 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 not specified 48
GSM1100109 LN+ endocrine? (0=no, 1=yes): 0 5.88 G3 25 CMF 5.88 5.88 not specified PgR- invasive ductal carcinoma He- not specified ER+ 1 not specified 61
GSM1100108 LN- endocrine? (0=no, 1=yes): 0 1.17 G3 20 none 1.17 6.50 not specified PgR- medullary carcinoma He- not specified ER- not specified not specified 42
GSM1100107 LN- endocrine? (0=no, 1=yes): 1 3.50 G1 40 tamoxifen 3.50 4.33 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 77
GSM1100106 LN- endocrine? (0=no, 1=yes): 1 NA G1 40 tamoxifen NA NA NA PgR+ papillary carcinoma He- NA ER+ 1 NA 81
GSM1100105 LN- endocrine? (0=no, 1=yes): NA 4.00 G3 23 NA 4.00 4.00 not specified PgR- invasive ductal carcinoma He+ not specified ER- NA not specified 42
GSM1100104 LN- endocrine? (0=no, 1=yes): 1 2.29 G3 36 Tam+ACx4 cycles 2.29 2.88 1 PgR- invasive ductal carcinoma He+ not specified ER+ 1 1 38
GSM1100103 LN+ endocrine? (0=no, 1=yes): 0 0.79 G3 30 ACx4 cycles 0.79 1.46 1 PgR- invasive ductal carcinoma He+ not specified ER- 1 1 51
GSM1100102 LN- endocrine? (0=no, 1=yes): 1 5.58 G1 15 Tam+CMFx6 cycles 5.58 5.79 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 60
GSM110010 LN+ endocrine? (0=no, 1=yes): 1 6.29 G3 45 Tam+ACx4 cycles 6.29 6.29 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 52
GSM1100100 LN- endocrine? (0=no, 1=yes): 0 0.75 G3 35 ACx4 cycles 0.75 0.75 not specified PgR- invasive ductal carcinoma He- not specified ER- 1 not specified 48
GSM1100099 LN- endocrine? (0=no, 1=yes): 0 4.17 G3 22 AC 4.17 4.25 not specified PgR- invasive ductal carcinoma He- not specified ER- 1 not specified 42
GSM1100098 LN+ endocrine? (0=no, 1=yes): 0 5.08 G3 30 ACx4 cycles 5.08 5.08 not specified PgR- invasive ductal carcinoma He- not specified ER- 1 not specified 48
GSM1100097 LN+ endocrine? (0=no, 1=yes): 0 4.38 G3 35 ACx8 cycles; taxol 4.38 4.38 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 34
GSM1100096 LN+ endocrine? (0=no, 1=yes): 0 2.21 G1 80 CAFx6 cycles 2.21 3.04 1 PgR+ invasive lobular carcinoma He- 1 ER+ 1 1 29
GSM1100095 LN+ endocrine? (0=no, 1=yes): 1 3.13 G1 21 tamoxifen 3.13 4.38 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 86
GSM1100094 LN+ endocrine? (0=no, 1=yes): 0 1.29 G3 35 CAF 1.29 1.38 1 PgR- invasive ductal carcinoma He+ 1 ER- 1 1 54
GSM1100093 LN+ endocrine? (0=no, 1=yes): NA 0.13 G3 22 NA 0.13 0.38 1 PgR- invasive ductal carcinoma He+ 1 ER- NA 1 46
GSM1100092 LN- endocrine? (0=no, 1=yes): 0 5.54 G3 40 ACx4 cycles 5.54 5.54 not specified PgR- invasive ductal carcinoma He- not specified ER- 1 not specified 41
GSM110009 LN+ endocrine? (0=no, 1=yes): 1 1.96 G3 40 tamoxifen 1.96 1.96 1 PgR+ invasive ductal carcinoma He- not specified ER+ 1 1 80
GSM1100090 LN+ endocrine? (0=no, 1=yes): 0 4.83 G3 20 CAF 4.83 4.83 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 not specified 45
GSM1100089 LN- endocrine? (0=no, 1=yes): 0 5.08 G3 30 ACx4 cycles 5.08 5.08 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 not specified 64
GSM1100088 LN+ endocrine? (0=no, 1=yes): 0 0.88 G3 35 none 0.88 1.00 1 PgR- invasive ductal carcinoma He+ not specified ER- not specified 1 62
GSM1100087 LN+ endocrine? (0=no, 1=yes): 1 0.00 G3 25 Arimidex+CMFx2 cycles 0.00 2.08 1 PgR+ invasive ductal carcinoma He+ 1 ER+ 1 1 62
GSM1100086 LN+ endocrine? (0=no, 1=yes): 0 1.96 G3 30 CAF 1.96 1.96 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 58
GSM1100085 LN+ endocrine? (0=no, 1=yes): 0 5.25 G3 25 AC 5.25 5.29 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 45
GSM1100084 LN+ endocrine? (0=no, 1=yes): 0 3.96 G3 20 ACx4 cycles 3.96 4.63 1 PgR- invasive ductal carcinoma He+ 1 ER- 1 1 54
GSM1100083 LN+ endocrine? (0=no, 1=yes): 0 4.00 G3 50 ACx4 cycles 4.00 4.00 not specified PgR- invasive ductal carcinoma NA not specified ER- 1 not specified 44
GSM1100082 LN+ endocrine? (0=no, 1=yes): 1 2.04 G3 30 tamoxifen 2.04 2.25 1 PgR- invasive ductal carcinoma He+ 1 ER+ 1 1 74
GSM110008 LN+ endocrine? (0=no, 1=yes): 0 4.00 G3 35 ACx4 cycles 4.00 4.33 not specified PgR- invasive lobular carcinoma He+ not specified ER- 1 not specified 52
GSM1100080 LN- endocrine? (0=no, 1=yes): 0 1.00 G3 60 ACx4 cycles 1.00 5.00 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 not specified 55
GSM1100079 LN- endocrine? (0=no, 1=yes): 1 0.13 G1 38 tamoxifen NA 0.13 not specified PgR+ mucinous carcinoma He- not specified ER+ 1 not specified 66
GSM1100078 LN+ endocrine? (0=no, 1=yes): 0 4.88 G3 32 CAF 4.88 4.88 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 47
GSM1100077 LN- endocrine? (0=no, 1=yes): 1 4.46 G3 20 tamoxifen 4.46 4.46 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 55
GSM1100076 LN- endocrine? (0=no, 1=yes): 1 5.46 G1 15 tamoxifen;goserelin 5.46 5.46 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 45
GSM1100075 LN- endocrine? (0=no, 1=yes): 0 1.54 G3 40 ACx4 cycles 1.54 5.46 not specified PgR- invasive ductal carcinoma He+ not specified ER- 1 not specified 34
GSM1100074 LN- endocrine? (0=no, 1=yes): 0 5.00 G2 35 ACx4 cycles 5.00 5.00 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 47
GSM1100073 LN- endocrine? (0=no, 1=yes): 1 5.33 G2 15 tamoxifen 5.33 5.33 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 49
GSM1100072 LN- endocrine? (0=no, 1=yes): 1 5.58 G2 12 tamoxifen 5.58 5.58 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 64
GSM110007 LN- endocrine? (0=no, 1=yes): NA NA G2 17 NA NA 0.08 NA PgR+ invasive ductal carcinoma He+ not specified ER+ NA NA 66
GSM1100070 LN+ endocrine? (0=no, 1=yes): NA 4.00 G2 40 NA 4.00 4.50 not specified PgR+ invasive ductal and lobular carcinoma He- not specified ER- NA not specified 46
GSM1100069 LN+ endocrine? (0=no, 1=yes): 1 4.83 G2 20 tamoxifen 4.83 4.92 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 73
GSM1100068 LN- endocrine? (0=no, 1=yes): 1 4.88 G2 15 Tam+CMFx6 cycles 4.88 4.88 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 46
GSM1100067 LN+ endocrine? (0=no, 1=yes): NA 4.50 G2 30 NA 4.50 4.50 not specified PgR- invasive ductal carcinoma He- not specified ER+ NA not specified 42
GSM1100066 LN+ endocrine? (0=no, 1=yes): 1 1.67 G2 60 Tam+CAFx2 cycles 1.67 1.75 1 PgR- invasive ductal carcinoma He+ 1 ER+ 1 1 46
GSM1100065 LN+ endocrine? (0=no, 1=yes): 0 0.42 G2 24 none 0.42 0.42 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ not specified not specified 44
GSM1100064 LN+ endocrine? (0=no, 1=yes): 1 4.92 G2 19 tamoxifen 4.92 4.92 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 55
GSM1100063 LN- endocrine? (0=no, 1=yes): 1 4.75 G2 21 tamoxifen 4.75 4.75 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 57
GSM1100062 LN+ endocrine? (0=no, 1=yes): 0 5.17 G2 23 CAF 5.17 5.17 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 40
GSM110006 LN- endocrine? (0=no, 1=yes): 0 4.67 G2 35 CMF 4.67 4.67 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 44
GSM1100060 LN+ endocrine? (0=no, 1=yes): 0 5.67 G2 30 CAF 5.67 5.67 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 46
GSM1100059 LN- endocrine? (0=no, 1=yes): 1 4.67 G2 40 Tam+ACx4 cycles 4.67 4.67 not specified PgR+ invasive ductal carcinoma He- not specified ER- 1 not specified 35
GSM1100058 LN- endocrine? (0=no, 1=yes): 0 0.67 G2 15 none 1.25 4.58 not specified PgR+ invasive ductal carcinoma He- not specified ER+ not specified 1 55
GSM1100057 LN- endocrine? (0=no, 1=yes): 0 2.83 G2 25 none 2.83 2.83 1 PgR- invasive ductal carcinoma He+ not specified ER- not specified 1 67
GSM1100056 LN+ endocrine? (0=no, 1=yes): 1 0.67 G2 40 tamoxifen 0.92 5.42 not specified PgR+ invasive ductal carcinoma He+ not specified ER- 1 1 75
GSM1100055 LN- endocrine? (0=no, 1=yes): 0 0.04 G2 15 anastrozole;taxol 0.04 3.08 1 PgR- invasive lobular carcinoma He- 1 ER+ 1 1 48
GSM1100054 LN+ endocrine? (0=no, 1=yes): 1 5.25 G2 23 Tam+CAFx6 cycles 5.25 5.25 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 49
GSM1100053 LN+ endocrine? (0=no, 1=yes): 0 5.00 G2 25 CAF 5.00 5.00 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 69
GSM1100052 LN+ endocrine? (0=no, 1=yes): 1 NA G2 25 Tam+ACx8;taxol NA NA NA PgR- invasive ductal carcinoma He+ NA ER+ 1 NA 51
GSM110005 LN- endocrine? (0=no, 1=yes): 1 6.33 G2 20 Tam+CMFx6 cycles 6.33 6.33 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 60
GSM1100050 LN- endocrine? (0=no, 1=yes): 1 5.58 G2 35 tamoxifen 5.58 5.58 not specified PgR- invasive ductal carcinoma He+ not specified ER+ 1 not specified 77
GSM1100049 LN+ endocrine? (0=no, 1=yes): 0 5.75 G2 22 CMF 5.75 5.92 not specified PgR+ invasive ductal carcinoma He- not specified ER- 1 not specified 53
GSM1100048 LN+ endocrine? (0=no, 1=yes): 0 5.83 G2 25 CAF 5.83 5.83 not specified PgR+ invasive ductal carcinoma He- not specified ER- 1 not specified 50
GSM1100047 LN- endocrine? (0=no, 1=yes): 0 5.79 G2 18 CMF 5.79 5.79 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 52
GSM1100046 LN- endocrine? (0=no, 1=yes): 1 6.00 G2 18 tamoxifen 6.00 6.00 not specified PgR- invasive ductal carcinoma He- not specified ER+ 1 not specified 53
GSM1100045 LN- endocrine? (0=no, 1=yes): 0 4.04 G2 15 none 4.04 4.08 not specified PgR- invasive ductal carcinoma He+ not specified ER- not specified not specified 46
GSM1100044 LN- endocrine? (0=no, 1=yes): NA 5.63 G2 20 NA 5.63 5.63 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ NA not specified 48
GSM1100043 LN+ endocrine? (0=no, 1=yes): 0 2.00 G2 60 ACx4 cycles 2.00 2.25 1 PgR- invasive ductal carcinoma He+ not specified ER- 1 1 54
GSM1100042 LN- endocrine? (0=no, 1=yes): 1 6.25 G2 25 tamoxifen 6.25 6.25 not specified PgR- invasive ductal carcinoma He+ not specified ER+ 1 not specified 69
GSM110004 LN- endocrine? (0=no, 1=yes): 1 2.63 G2 25 Tam+CMFx6 cycles 2.63 2.63 not specified PgR+ invasive ductal carcinoma He+ not specified ER+ 1 not specified 40
GSM1100040 LN- endocrine? (0=no, 1=yes): 1 5.88 G2 35 tamoxifen 5.88 6.04 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 69
GSM1100039 LN- endocrine? (0=no, 1=yes): 1 4.29 G2 30 tamoxifen 4.29 4.29 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 69
GSM1100038 LN+ endocrine? (0=no, 1=yes): 0 1.13 G2 30 ACx4 cycles 1.13 1.13 1 PgR- invasive ductal carcinoma He+ not specified ER- 1 1 62
GSM1100037 LN- endocrine? (0=no, 1=yes): 1 6.17 G2 20 Tam+ACx4 cycles 6.17 6.17 not specified PgR+ invasive ductal carcinoma He- not specified ER+ 1 not specified 41

Tags

  • breast
  • breast cancer
  • cancer
  • genome

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use